Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Akari Therapeutics
(NQ:
AKTX
)
2.410
USD
-0.140 (-5.49%)
Official Closing Price
Updated: 7:10 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Akari Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 05, 2021
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 102.76% to $5.86 during Friday's pre-market ...
Tags
EYES
BZI/TFM
Movers
From
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 04, 2021
Gainers Fulgent Genetics (NASDAQ:FLGT) stock moved upwards by 29.19% to $110.5 during Thursday's after-market session. This ...
Tags
ACOR
SLRX
Market News
From
Benzinga
Akari Therapeutics Announces a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR) for Nomacopan in Trauma
March 04, 2021
Study of porcine model of blast injury and haemorrhagic shock underway with USAISR as part of the development of a clinical path for the use of nomacopan to treat trauma
From
GlobeNewswire News Releases
Akari Therapeutics' PASylated Nomacopan Shows Promising Action In Animal Studies
February 25, 2021
Akari Therapeutics Plc(NASDAQ:AKTX)announces new datafrom PASylated nomacopan published in the journal ...
Tags
FDA
Market News
Biotech
From
Benzinga
Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
February 25, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FREQ
ARNA
NK
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 22, 2021
Gainers Insulet (NASDAQ:PODD) stock moved upwards by 15.87% to $297.22 during Monday's after-market session. Today's trading ...
Tags
BZI/TFM
After/Hours Center
PAVM
From
Benzinga
80 Biggest Movers From Friday
February 22, 2021
Gainers Energous Corporation (NASDAQ: WATT) shares surged 94.4% to close at $7.23 on Friday following Bloomberg report Apple is ...
Tags
Benzinga
Pre/Market Outlook
News
From
Benzinga
Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
February 01, 2021
From
GlobeNewswire News Releases
101 Biggest Movers From Yesterday
January 29, 2021
Gainers New Concept Energy, Inc. (NYSE: GBR) shares jumped 959.3% to close at $25.00 on Thursday. Marine Petroleum Trust ...
Tags
CVLB
NNOX
AAU
From
Benzinga
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TMDI
DTIL
HALO
From
Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
HALO
DTIL
CLPT
From
Benzinga
54 Biggest Movers From Friday
January 19, 2021
Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares jumped 76.9% to close at $13.71 on Friday. ObsEva SA (NASDAQ: OBSV) ...
Tags
AT
Market News
SRNE
From
Benzinga
Stocks That Hit 52-Week Highs On Friday
January 15, 2021
This morning 150 companies reached new 52-week highs. Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm ...
Tags
BLBD
MBIO
BJRI
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 11, 2021
Gainers Iridex (NASDAQ:IRIX) stock rose 29.02% to $3.69 during Monday's after-market session. This security traded at a volume of ...
Tags
AMN
AVGR
General
From
Benzinga
Akari Therapeutics to Participate in Two January Virtual Investor Conferences
January 06, 2021
From
GlobeNewswire News Releases
Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress
December 11, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal
December 11, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
December 03, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
PTCT
BNTC
VRTX
From
Benzinga
Akari Therapeutics to Present Phase II Data from Bullous Pemphigoid Trial at European Academy of Dermatology and Venereology (EADV) Virtual Congress October 29
October 27, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces Further Clinical Trial Progress Using Nomacopan to Treat COVID-19 Pneumonia
October 06, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces Successful Scientific Advice Meeting with the European Medicines Agency (EMA) Establishing a Clear Path in Both U.S. and Europe for a Pivotal Phase III Study of Nomacopan
October 01, 2020
From
GlobeNewswire News Releases
Akari Therapeutics to Present Its Phase III Plans at the International Pemphigus & Pemphigoid Foundation (IPPF) Patient Education Conference
September 29, 2020
From
GlobeNewswire News Releases
Akari Therapeutics to Participate in Two September Virtual Investor Conferences
September 10, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Reports Second Quarter 2020 Financial Results and Highlights Recent Clinical Progress
September 01, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces International Clinical Development Program of Nomacopan for the Potential Treatment of COVID-19 Pneumonia
August 31, 2020
From
GlobeNewswire News Releases
Akari Therapeutics Announces Successful End-of-Phase II Meeting With FDA to Initiate Pivotal Phase III Study for Treatment of Bullous Pemphigoid With Nomacopan
August 12, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
July 26, 2020
Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
July 26, 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured ...
Tags
AGIO
PFE
Top Stories
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.